Asimov Press β’ 206 implied HN points β’ 23 Feb 25
- Lenacapavir is a new injectable drug that can prevent HIV for up to six months, showing a higher effectiveness than daily pills.
- The drug is being offered at reduced prices in many low-income countries, but there are concerns about access and affordability in some regions.
- Despite its promise, lenacapavir's future depends on getting it to those who need it, especially given changes in government funding for HIV prevention programs.